_Detection_Kit_2.jpg)
The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit
Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- L/C,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- pcr test kit, solgent, covid-19, sars-cov-2
- Category
- Medical Test Kit
EC Corporation
South Korea
- Verified Certificate
-
4
| Product name | The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit | Certification | FDA , CE |
|---|---|---|---|
| Category | Medical Test Kit | Material | - |
| Keyword | pcr test kit , solgent , covid-19 , sars-cov-2 | Unit Size | 60.0 * 95.0 * 55.0 mm |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 0 |
| Supply type | Available | HS code | 3822001020 |
Product Information
The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS- CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid- turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider.
- PCRC is included
- The LoD(Limit of Detection) : 200 copies/mL
- High specificity (Not detect viruses and bacteria other than the SARS-CoV-2)
The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS- CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid- turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider.
The DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.
“DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit” are being exported to more than 60 countries including the U.S.A, Europe and the Middle East.
Certificates: MFDS EUA, FDA EUA, CE IVD marked, Canada I.O etc.
35 CE marked products and RUO diagnostic products Including tuberculosis, sexually transmitted diseases, pneumonia, etc.
ISO 13485:2016, ISO 9001:2015, KGMP
- Product Info Attached File
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | Express |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | L/C,T/T | Shipping time | Negotiable |
- President
- Baek Doo Won
- Address
- 705 Yangwharo 161, Mapo-gu, Seoul, Korea
- Product Category
- Face Shield,Medical Face Mask,Medical Test Kit,Surgical Glove,Surgical Gown
- Year Established
- 2015
- Company introduction
-
EC Corporation is a global distributor that carries diagnosis kit, protective gear, sterilization
equipment and more for current COVID-19 pandemic.
- Main Markets
-
Saudi Arabia
U.A.E.
- Main Product
_Detection_Kit_2.jpg "The DiaPlexQ Novel Coronavirus _2019_nCoV_ Detection Kit_1")
